` BLT (BLIS Technologies Ltd) vs NZX All Share Comparison - Alpha Spread

BLT
vs
NZX All Share

Over the past 12 months, BLT has underperformed NZX All Share, delivering a return of -12% compared to the NZX All Share's 3% growth.

Stocks Performance
BLT vs NZX All Share

Loading
BLT
NZX All Share
Add Stock
www.alphaspread.com

Performance Gap
BLT vs NZX All Share

Loading
BLT
NZX All Share
Difference
www.alphaspread.com

Performance By Year
BLT vs NZX All Share

Loading
BLT
NZX All Share
Add Stock

Competitors Performance
BLIS Technologies Ltd vs Peers

NZX All Share
BLT
LLY
JNJ
NOVO B
ROG
Add Stock

BLIS Technologies Ltd
Glance View

Market Cap
19.2m NZD
Industry
Pharmaceuticals

BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. The company is headquartered in Dunedin, Otago. The company went IPO on 2001-07-30. The firm is also engaged in supply of healthcare ingredients and the manufacture of part and finished goods and food products for sale in domestic and international markets. The firm supplies BLIS-branded finished goods. The firm's products include BLIS K12 and BLIS M18, which are oral probiotics providing protection for ear, nose and throat health, halitosis (bad breath), gums and teeth health and immune support. The firm distributes its products through Stratum Nutrition in North America, NZPR Group in China, and Bluestone Pharma in Europe and Middle East. Its other BLIS branded products include Throat Guard EVERYDAY BLIS K12, Travel Guard BLIS K12, Fresh Breath Kit K12 and Toddler Protect BLIS K12 Powder for Toddlers.

BLT Intrinsic Value
0.007 NZD
Overvaluation 52%
Intrinsic Value
Price
Back to Top